Answers are grounded in this paper and cite their sources.
Over the past 10 years, fully endoscopic lumbar interbody fusion (FE-LIF) has been widely reported as a rational alternative to minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF), and several FE approaches for interbody fusion have been published. The short-term surgical outcomes of FE-LIF are reportedly superior to those of MIS-TLIF and conventional posterior LIF in terms of intraoperative blood loss and short-term back pain. However, the complication rate, medium-term clinical outcomes, and fusion rate have not been reported to be different in all uncontrolled studies. The challenges associated with FE-LIF include a longer operative time, which means a steep learning curve, and limited surgical indications, which leads to patient selection bias. FE-LIF is an excellent surgical option for treating degenerative disc disease, spinal instability, and spondylolisthesis. Although the amount of evidence is very small in existing studies and the long-term follow-up data are limited, this technique shows favorable clinical outcomes in selected patients.
No takes yet. Share an insight, caveat, or question.
Nakajima et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: